Clinical trial
Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by…
NCT00121420 · Pharmacyclics LLC., Industry · Terminated
Key facts
| NCT number | NCT00121420 |
|---|---|
| Title | Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases |
| Official title | Phase II Trial of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases |
| Lead sponsor | Pharmacyclics LLC., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasm Metastasis, Brain Neoplasms |
| Intervention type | Drug |
| Interventions | Motexafin gadolinium |
| Enrollment | 45 |
| First posted | Jul 21, 2005 |
| Last update posted | May 9, 2014 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: